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Abstract
Toxoplasma gondii belongs to the phylum the Apicomplexa, a phylum that mainly consists of
difficult to study intracellular protozoan parasites. The zoonosis caused by T. gondii is called
toxoplasmosis. Even though most healthy individuals infected will be asymptomatic, a T. gondii
infection can be lethal for individuals with a compromised immune system. Non-specific drugs
exist to treat toxoplasmosis, but these are typically not able to eliminate T. gondii completely
from the infected host and infection reoccurs. The proteins involved in T. gondii’s unique cell
cycle are considered prime targets for the development of new anti-parasitic drugs. However, in
order to target vital and unique T. gondii proteins these must first be identified and their
interactions characterized. One such potential protein would be the putative T. gondii cell cycle
protein TgCyc2. TgCyc2 has previously been found to interact with TgIMC1 and TgCDK1 in a
yeast two-hybrid screen. It is hypothesized that TgCyc2 targets TgCDK1 to a specific
suborganellar location by binding to the inner membrane protein TgIMC1. Here an initial
attempt to elucidate this mechanism via a yeast two-hybrid test is described.
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Chapter 1: Introduction
The Apicomplexa and Toxoplasma gondii
Over 6000 protozoan species belong to the phylum called the Apicomplexa and a
majority of them are described as intracellular parasites (Morrison, 2009). Most of the
Apicomplexa parasites share similar features including a subpellicular network (SPN), rhoptries,
micronemes, apical polar rings, the apical complex, and an inner membrane complex (IMC)
(Morrison, 2009; Morrissette & Sibley, 2002).
One prevalent and commonly studied Apicomplexa is Toxoplasma gondii. T. gondii has a
worldwide distribution and high prevalence in the human population (Tenter, Heckeroth, &
Weiss, 2000). This parasite causes the disease toxoplasmosis. However, the majority of healthy
individuals will either be asymptomatic or only have minor flu symptoms when they become
infected. The situation is worse for vulnerable populations exposed to T. gondii. The
immunocompromised can suffer reoccurring infections because current drugs are unable to clear
the infection and the infection can lead to life threatening encephalitis (Tenter et al., 2000).
A second vulnerable population is pregnant women or more specifically their unborn
children. If a mother becomes infected for the first time T. gondii can be passed from the mother
to the unborn child, which can cause birth defects or in severe cases death (Tenter et al., 2000).
Additionally, T. gondii can cause rare events of ocular disease in healthy individuals and studies
are investigating the association between T. gondii infections and mental health disorders
(Wilking, Thamm, Stark, Aebischer, & Seeber, 2016).
Other clinically and agriculturally important Apicomplexans include the Plasmodium
species responsible for malaria, the Eimeria species, which infect poultry and cattle, and
Theileria species, which are tick borne cattle pathogens (Morrissette & Sibley, 2002). There is a
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lack of effective treatment options for many of these parasites, including T. gondii and the
Plasmodium species. One area of focus among researchers is to study the Apicomplexa’s cell
cycle process to find new drug targets (Wei, Wang, & Liu, 2013).
Unique Cell Cycle Processes
The Apicomplexa are characterized by unique cell cycle processes, which differ from the
typical eukaryotic process of mitosis. Three different Apicomplexa cellular division mechanisms
have been described endodyogeny, schizogony and endopolygeny (Francia & Striepen, 2014).
In humans T. gondii exists in what is known as the tachyzoite stage. The tachyzoite proliferate
via endodyogeny and a key virulence factor for T. gondii is proliferation (Gubbels, White, &
Szatanek, 2008). T. gondii utilizes endodyogeny when it is inside an intermediate host i.e. in
humans, but can also reproduce via schizogony, which it does in the cat intestine (Dubey,
Lindsay, & Speer, 1998; Francia & Striepen, 2014).
Endodyogeny has been described as the simplest cell cycle variation within the
Apicomplexa with schizogony, utilized by Plasmodium species among others, and endopolygeny
as more complex variations (Francia & Striepen, 2014). The ability of T. gondii to switch
between the process of endodyogeny and schizogony could be considered a key to its success
and the ability to switch also indicates that there is an intricate process for controlling cell cycle
progression (Francia & Striepen, 2014; Gubbels et al., 2008).
Considering that the Apicomplexa life cycles are overlapping studying the molecular
mechanisms for one species in the phylum can lead to insight into several others (Ferguson et al.,
2008). Endodyogeny and schizogeny differ mainly on three accounts: the amount of progeny
made (two for endodyogeny versus sixteen to a hundred for schizogony), if progeny
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development goes via a cytoplasmic or the peripheral route, and the intact or loss of
specialization of the mother cell (Gubbels et al., 2008; Morrissette & Sibley, 2002).
A comparative approach to learn about the Apicomplexa occurs relatively frequently in
the literature. For instance protein homologues of MORN1 were followed in developing T.
gondii, three Eimeria species, and Plasmodium falciparum and implicated in IMC formation for
all three (Ferguson et al., 2008). T. gondii is often considered to be a model organism for the
Apicomplexa because of its relative ease of manipulation in the laboratory setting as well as its
division via endodyogeny (Kim & Weiss, 2004).
Regulation of Endodyogeny
Entry into endodyogeny by T. gondii is marked by duplication of Golgi and centrioles in
the G1 phase (Gubbels et al., 2008). At about the same time point DNA replication begins (Hu et
al., 2002). One checkpoint during endodyogeny is suggested to be present between G1 and S
termed START (Gubbels et al., 2008). Another potential checkpoint could be present during
chromosome replication (Gubbels et al., 2008). The G2 phase commonly found in other
eukaryotic organisms is thought to be either short or not present at all during the T. gondii cell
cycle (Gubbels et al., 2008).
A variety of different regulatory elements are thought to be controll T. gondii
endodyogeny. Cyclin dependent kinases (CDKs) and cyclins are main regulators of the typical
eukaryotic cell cycle process and have also been found to have regulatory roles in the
Apicomplexa (Wei et al., 2013). Other regulatory factors that have been described are never in
mitosis kinase (NIMA), transcription factors, and RNA recognition motif 1 (Francia & Striepen,
2014).
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The kinases of T. gondii can be classified into eukaryotic kinase groups, but 78 out of 108
protein kinases predicted do not appear to have orthologues in either human or yeast kinases
(Wei et al., 2013). This lack of conservation of T. gondii kinases is an indication of how unique
Apicomplexa proteins can be and that the proteins might behave in unusual manners. Further, it
suggests that unique cell cycle proteins could serve as drug targets (Wei et al., 2013).
Cyclin Dependent Kinases and Cyclins
Cyclin dependent kinases are considered to be members of the family of serine/threonine
kinases. A CDK becomes activated when it binds to a cyclin and carries on its function to
phosphorylate its substrate. This phosphorylation event might lead to cell cycle progression or
inhibition depending on the state of the cell cycle. Cyclins are recognized as proteins that
fluctuate i.e. vary in concentration during the cell cycle and regulate the activity of CDKs by
binding to them. Further, cyclins can be identified by the presence of a cyclin box, which is a
conserved domain at the C-terminal end (Nugent, Alfa, Young, & Hyams, 1991).
Bioinformatics analysis results have estimated that the T. gondii genome contains
approximately 20 CDKs and close relatives to the CDKs (Peixoto et al., 2010). Further, cyclins
have been isolated in T. gondii via the yeast two-hybrid screen and in P. falciparum (Kvaal,
Radke, Guerini, & White, 2002; Waters, Woodard, & Prigge, 2000). Many questions still remain
to be answered about the Apicomplexa CDK’s and cyclins such as their substrates, interaction
partners, localization, and role in controlling the diverse cell cycle modes observed in these
parasites.
TgCyc2 – TgIMC1 – TgCDK1
The Putative Toxoplasma gondii Cyclin 2. Putative T. gondii cyclin 2 (TgCyc2), coding
sequence (TGVEG_290020), is a 288 amino acid protein. This protein has been found to interact
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with TgCDK1 and TgIMC1 in a yeast two-hybrid screen (unpublished Kvaal). Bioinformatics
analysis of the coding sequence has indicated the presence of a cyclin box between bases 789 –
843 (Barnes, 2016). Further, the bioinformatics software Cyclinpred predicted that TgCyc2 was
a cyclin protein (Noyes, 2013). However, overexpression of TgCyc2 in yeast has been found to
induce cell cycle arrest in S. cerevisiae (Wade-Ferrell, 2011). This could be due to the toxicity
of large amounts of TgCyc2 to yeast or because TgCyc2 is a cell cycle inhibitory protein.
Relatively little beyond this is currently known about TgCyc2.
The TgIMC1 Inner Membrane Protein. On the cytoplasmic face of the inner membrane
several Apicomplexa, including both T. gondii and P. falciparum, have a subpellicular network
(Khater, Sinden, & Dessens, 2004; Mann & Beckers, 2001). It is primarily thought that the
subpellicular network provides structural integrity (Mann & Beckers, 2001). Two integral
proteins associated with the T. gondii subpellicular network are the two inner membrane
proteins, TgIMC1 and TgIMC2 (Mann & Beckers, 2001). TgIMC1’s coding sequence is
(TGME49_031640) and was isolated by Mann et al (Mann & Beckers, 2001). Further, TgIMC1
homologues have been found in other Apicomplexa such as P. falciparium PfIMC1 and
Plasmodium berghei PbIMC1a (Khater et al., 2004; Mann & Beckers, 2001).
The progress of subpellicular network assembly during T. gondii development was
studied by combining TgIMC1 with the fluorescent protein YFP while performing time-lapse
video microscopy (Hu et al., 2002). First the daughter cell IMC appears when the DNA content
is about 1.8N, which has been suggested as one checkpoint or pause in endodyogeny (Gubbels et
al., 2008; Hu et al., 2002). This appearance of the IMC includes the appearance of the TgIMC1
protein, which is present from there on during development. Later, two dome shaped IMCs with
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underlying SPNs appear. This begins the process of separating organelles and the membrane
starts to surround a horseshoe shaped nucleus (Dubey et al., 1998; Hu et al., 2002).
Towards the IMC formation completion and before daughter cells leaves the mother, the
TgIMC1 protein is proteolytically processed, which results in removal of TgIMC’s cysteine tail
(Mann, Gaskins, & Beckers, 2002). This event coincides with the daughter cell’s IMC gaining
structural integrity i.e. this prevents the SPN from being detergent extracted, which is a marker
of a mature T. gondii (Mann et al., 2002).
Cyclin Dependent Kinase 1. TgCDK1, coding sequence (TGVEG_218220), was isolated
by Wastling et al. in 1998 and re-isolated by Khan et al. in 2002, who further characterize this as
a CDK (Khan, Tang, Qin, & Kim, 2002; Wastling & Kinnaird, 1998). Several conserved CDK
domains have been identified in TgCDK1 and these include the ATP binding domain, the
PSAIRE region, and the catalytic KLADFGLAR region (Khan et al., 2002).
Alignments results show that TgCDK1 have higher similarities to other Apicomplexans
kinases then human and yeast. For example there is a 75% homology with P. falciparium
compare to 63% homology to the human CDC2 (Khan et al., 2002). The functionality of
TgCDK1’s conserved domains has been further assessed. Co-immunoprecipitation found that
mammalian cyclins A, B1, D3 and E bind to TgCDK1, and kinase activity was established in
COS-7 cells (Khan et al., 2002). Further, expression of a double negative mutant of TgCDK1
leads to the accumulation of T. gondii in S-phase (Khan et al., 2002).
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Chapter 2: Hypothesis
As stated previously TgCyc2 has been found to interact with both TgCDK1 and TgIMC1
(unpublished, Kvaal). The ability of TgCyc2 to bind to both TgIMC1 and TgCDK1 has lead to
an overarching hypothesis on how these interactions could be relevant for T. gondii’s progression
through the cell cycle. If TgCyc2 binds TgCDK1 during the cell cycle then TgCyc2 can target
TgCDK1 to a suborganellar location by a secondary interaction to TgIMC1. TgIMC1 is present
in the developing daughter membrane and could serve as a spatial regulator of the cell cycle by
interacting with the TgCyc2-TgCDK1 complex. Once TgCyc2 is bound to TgIMC1, the
TgCDK1 would be in position to phosphorylate its target at a specific suborganellar location.
In order to evaluate this overarching hypothesis the purpose of this project was to
determine if TgCyc2 binds TgIMC1 and TgCDK1 at different functional domains or at the same
or overlapping domains. This led to the following research hypotheses:

Hypothesis 1: TgCyc2 has a functional domain separate from the cyclin box area that binds the
TgIMC1 protein allowing for TgCyc2 to interact with both TgIMC1 and TgCDK1
simultaneously.

Hypothesis 2: TgCyc2 binds both the TgIMC1 protein and the TgCDK1 protein in the cyclin box
area, which does not allow for simultaneous interactions.

The primary research goal was to test these two hypotheses by making three successively
shorter TgCyc2 fragments with the aim of leaving only the cyclin box in the last TgCyc2
fragment. These fragments would then be cloned and expressed in the yeast two-hybrid test to
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test for interaction with TgIMC1. If the TgCyc2 interaction with TgIMC1 takes place in the
beginning of the protein, i.e. not in the cyclin box, then at the minimum the shortest fragment
expressed in the yeast two-hybrid test would not lead to a protein – protein interaction. However,
if the interaction between TgCyc2 and TgIMC1 takes place in the cyclin box a protein-protein
interaction would still be observed with the shortest protein fragment.
The concept that cyclins target CDKs to subcellular locations is not a novel idea. It was
found that when cyclin B1 binds to CDK1 the complex is transported from the nucleus to the
cytoplasm because the complexation creates a localization signal (Hagting, Karlsson, Clute,
Jackman, & Pines, 1998). Another even more relevant example is the discovery that cyclin Y
complexes with the inner membrane via an N-terminal motif, which brings CDK14 closer to its
substrate (Lim & Kaldis, 2013).

15
Chapter 3: Materials and Methods
TgCyc2 fragment PCR amplification
The Toxoplasma gondii cyclin 2 fragments were amplified from a T. gondii cDNA library
provided by Christopher Kvaal, Ph.D via PCR amplification. Forward primers with NdeI
restriction enzyme sites were designed for PCR amplification of three successively shorter
TgCyc2 T. gondii fragments. The reverse primer was the same in each amplification reaction and
designed with a BamHI restriction enzyme site.

Forward TgCyc2 fragment primers
TgCyc 2 (B) – 748 bp long
5’ ATTCCATATGGGCCGAGGTGTTTATAC 3’
TgCyc 2 (C) – 640 bp long
5’ ATTCCATATGCGTTTTCAACAGGGACG 3’
TgCyc 2 (D) – 520 bp long
5’ ATTCCATATGCACCCTTCTGTCCATCC 3’

Reverse TgCyc 2 fragment primer
TgCyc 2 (B – D) reverse primer
5’ TCGCGGATCCTCAGGCGCTGAAGAAGGCAGTCTC 3’

The resulting PCR products were verified with agarose gel electrophoresis run alongside a 1kb
molecular weight ladder. Confirmed bands were removed and gel purified using a gel
purification kit.
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Cloning and Bacterial Transformation
Restriction enzymes BamH1 and Nde1 were used to digest the PCR product fragments
and the pGBKT7 vector. The PCR products were ligated to the pGBKT7 GAL4-DNA binding
domain vector (DNA-BD). Full length TgCyc2 had previously been incorporated into the
pGBKT7 vector and full length TgIMC1 into the pGADT7 GAL4-DNA activation domain
vector (DNA-AD).
Each of the pGBKT7–TgCyc2 cloned fragments were mixed separately with competent
E. coli cells and incubated on ice for bacterial transformations. The tubes were heat shocked at
42°C for 45 seconds and rested on ice for 2 minutes. SOC media was added to the bacteria and
the bacteria was allowed to grow in a shaking incubator at 37°C for 45 minutes. Undiluted and a
one tenth dilution was plated on ampicillin LB plates. The plates were incubated overnight at
37°C. Colonies were selected and inoculated in ampicillin LB broth. A plasmid mini prep was
used to isolate plasmid DNA from the transformed E. coli.
Lithium Acetate Yeast Co-transformation
The yeast strain Y187 was grown on YPD plates at 30°C. An ample amount of colonies
were selected and inoculated in 20 ml YPD broth and grown in a shaking incubator at 30°C
overnight. The yeast from the overnight culture was transferred to a flask containing 100 ml
YPD. The fresh culture was allowed to grow for 3 hours in a shaking incubator at 30°C. After 3
hours the yeast was centrifuged for 2 minutes, the supernatant was discarded and the yeast was
re-suspended in 1XTE. This was pelleted and re-suspended in 1X TE/1X LiAc and divided into
1.5 ml micro centrifuge tubes. The micro centrifuge tubes were pelleted and supernatant
decanted.
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A transfection mix consisting of 50% PEG, 1M LiAc, carrier DNA, and 200 ng of either
of these combinations of plasmids 1) pGBKT7-FragmentC – pGADT7-TgIMC1, 2) pGBKT7FragmentD – pGADT7-TgIMC1, 3) pGBKT7-TgCyc2FullLength – pGADT7-TgIMC1, 4)
PEXpGBKT7-TgCyc2FullLenght – pGADT7-TgIMC1 was applied to each of the micro
centrifuge tubes containing yeast. The resulting preparation was mixed by vortex and heat
shocked at 42°C for 1 hour. The transformed yeast was plated on double drop out plates, which
were missing tryptophan and leucine to select for co-transformed yeast.
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Chapter 4: Results
I-Tasser Structure Predications
Each of the three fragments and the full length TgCyc2 was analyzed with the I-Tasser
structure and function prediction software (Yang et al., 2015). The software’s top protein
database hit for the full-length prediction was a CDK2/cyclin A in complex with the inhibitor N&-N1. Other hits in PBD were a CDK/CyclinB1 complex and CDK4/D-type complex. The GO
Ontology function predications made by I-Tasser were “protein kinase binding”, “regulation of
cell cycle” and “regulation of CDK” (Yang, Roy, & Zhang, 2013). The predicted functional area
corresponds to the 5 alpha-helical domain predicted to be the TgCyc2 cyclin box (Figure 1).

Figure 1: The I-Tasser functional prediction model generated for the full length TgCyc2. The
model is shown binding a ligand in the helical domain corresponding to the cyclin box. The balls
and stickballs are part of the representative ligand molecule.
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The full length TgCyc2 I-Tasser structure prediction model received a C-score of -3.61
(Figure 2). As the TgCyc2 was shortened the structure predictions made by I-Tasser became
more confident i.e. fragment B, C, and D received C-scores of -2.57, -0.71, and -0.11
respectively (Figure 3-5). This is consistent with the presence of the cyclin box at the C-terminal
end of TgCyc2, an area, which would be easier for the software to predict considering its
conserved features.

Figure 2: The I-Tasser structure prediction generated for the full-length TgCyc2 or
fragment A (288 amino acids long). The predicted model received a confidence score or C-score
of -3.61.
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Figure 3: The I-Tasser structure prediction generated for fragment B (228 amino acids long). The
predicted model received a C-score of -2.57.

Figure 4: The I-Tasser structure prediction generated for fragment C (192 amino acids long). The
predicted model received a C-score of -0.71.
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Figure 5. The I-Tasser structure prediction generated for fragment D (152 amino acids long). The
predicted model received a C-score of -0.11.

Two out of Three TgCyc2 Fragments were Amplified
Two out of three TgCyc2 fragments, C and D were amplified via PCR. Bands were
visualized with gel electrophoresis at approximately 640 base pairs and 520 base pairs for
fragment C and D respectively (Figure 6). No band was visualized for fragment B in the gel
(Figure 6). The bands indicating fragments of the expected size were cut out of the gel and gel
purified for subsequent cloning experiments.
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Frag. B

Frag. C

Frag. D

Ladder

Figure 6: Two bands corresponding to fragment C at 640 base pairs and fragment D at 520 base
pairs are visualized in lane 2 and 3 in the gel electrophoresis gel. This indicates that fragment C
and fragment D were successfully amplified with PCR, but fragment B was not.

Amplified TgCyc2 Fragments were Cloned
After gel purifying the PCR amplified fragments, they were inserted in to plasmid
pGBKT7 with BamHI and NedI restriction enzyme digest and subsequent ligation. In order to
confirm that the fragments had been successfully inserted into the plasmid a re-digest was
performed on 10µl of pGBKT7-fragmentC and pGBKT7-fragmentD. The re-digest was
visualized via gel electrophoresis and bands corresponding to the expected sizes of 640 base
pairs and 520 base pairs for fragment C and D respectively (Figure 7).
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pGBKT7
Frag. D
Cut
Frag. D

pGBKT7
Frag. C
Cut
Frag. C

Figure 7: The pGBKT7-fragmentC and pGBKT-fragmentD were re-digested with BamHI and
NedI, which reformed the PCR inserts at the expected sizes of 640 base pairs and 520 base pairs.
Lane one is uncut plasmid pGBKT7-fragmentD and lane two corresponds to the pGBKT7fragmentD cut plasmid. Lane 4 is the 1kb ladder used as a marker and lane 5 is empty. Lane 6 is
pGBKT7-fragmentC digested plasmid and lane 7 is pGBKT7-fragmentC uncut plasmid.

The pGBKT7-fragmentC and pGBKT7-fragmentD were transformed in E-coli and
selected for on ampicillin plates. Selected clones that grew on the ampicillin plates were further
cultured and plasmid mini-prep was performed to purify the cloned plasmids. After purification
the plasmids were used to co-transform yeast.
The pGBKT7-fragmentC, pGBKT7-fragmentD, pGBKT7-TgCyc2Full-Length, and
pGBKT7PEX-TgCyc2Full-Length (negative control) were co-transformed with pGADT7TgIMC1 into the yeast strain Y187. Successful transformation was indicated by the yeasts ability
to grow on double drop out plates that were lacking tryptophan and leucine.
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The Yeast-Two Hybrid Test has not been Completed
Project time constrains and PCR amplification mishaps among other factors have
prevented the completion of the fragment yeast-two hybrid test. Hence currently no conclusion
can be drawn on where the TgCyc2-TgIMC1 protein-protein interaction will take place.
However, if hypothesis number 1 is corroborated it is expected that as the fragments are
shortened the TgCyc2-TgIMC1 interaction will cease. The opposite is expected if hypothesis
number 2 is corroborated i.e. the last fragment containing the cyclin box will interact with
TgIMC1 in the yeast two-hybrid test.
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Chapter 5: Discussion
The Nature of the TgCyc2 – TgIMC1 – TgCDK1 Interaction Remains
The question still remains on the nature of the interaction between TgCyc2, TgIMC1, and
TgCDK1. However, with co-transformed yeast one could easily perform the fragment protein
yeast two-hybrid interaction test. Depending on the result of the yeast two-hybrid test these
results could indicate the potential presence of a unique targeting mechanism performed by
TgCyc2 on TgCDK1. On the other hand the results could indicate that TgCyc2 – TgIMC1 –
TgCDK1 cannot form a complex since the binding of TgCyc2 to both occur at the same location.
In addition to temporal control by cyclins, the hypothesis has emerged on the role of the
Apicomplexa cytoskeleton elements for spatial control over the cell cycle (Francia & Striepen,
2014). The existence of the TgCyc2 – TgIMC1 protein interaction could be support for the
hypothesis that structural elements provide spatial regulation of the cell cycle. Further, the
discovery that for example cyclin Y in mammals targets CDK14 to a specific inner membrane
position suggest that similar targeting mechanisms could be present in other eukaryotic
organisms (Lim & Kaldis, 2013). It will be interesting to see what information the yeast twohybrid test generates with the cyclin fragments.
If TgCyc2 were found to target TgCDK1 to a suborganellar location by binding TgIMC1,
then the TgCyc2 – TgIMC1 interaction would make for an attractive drug target. TgIMC1 is a
unique protein to the Apicomplexan, with the closest homology to articulins in Euglena species
(Mann et al., 2002). Therefore, a drug that inhibits the TgCyc2 – TgIMC1 interaction could lead
to minimal toxicity for the host. Nonetheless, inhibiting the interaction could potentially result in
cell cycle arrest for T. gondii by disrupting the TgCDK1 suborganellar localization.
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Yeast Two-Hybrid Method and Limitations
A yeast two-hybrid screen was originally used to identify that TgCyc2 interacts with
TgIMC1 and TgCDK1. This same method has previously been used to identify positive cyclin
interactions for T. gondii (Kvaal et al., 2002). However, limitations to the yeast two-hybrid
screen exist. There are concerns that the proteins will not fold properly when expressed or that
foreign proteins expressed in yeast will not receive its proper post-translational modifications
(Coates & Hall, 2003).
Post-translational modifications might be a concern for T. gondii proteins expressed in
yeast. For instance T. gondii tubulin proteins have been found to be post-translational modified,
which indicates that this is a potential issue for T. gondii yeast two-hybrid interactions (Xiao et
al., 2010). There is also a risk that the yeast two-hybrid screen finds artificial interactions
between proteins that normally would not be in proximity to each other nor expressed during the
same time (Coates & Hall, 2003). However, experimental evidence exists that show TgIMC1’s
expression throughout the development of the T. gondii daughter cells (Mann & Beckers, 2001).
Therefore, it would be expected that cell cycle proteins such as TgCyc2 and TgCDK1 would be
expressed at the same time as TgIMC1.
Further, there are some concerns about the proposed methodology. Protein fragments
that are successively shorter might not fold correctly. This might result in false negative proteinprotein interaction results in a yeast two-hybrid test, which is not due to a lack of functional
domain, but due to improper protein folding. Further, as the fragments become successively
shorter the transcriptional binding domain might become closer to the functional domain. The
presence of the binding domain could lead to steric hindrance and this could also lead to false
negative result (Coates & Hall, 2003).
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I-Tasser Function Predictions
The I-Tasser structure predictions showed an interesting trend were the confidence score
or C-score increased, as the TgCyc2 fragment became successively shorter -3.61 to -0.11. This
fit the idea that the cyclin box is present at the end of TgCyc2. I-Tasser searches the protein data
bank for known structures determined via for example x-ray diffraction (Yang et al., 2015). Due
to the fact that the cyclin box is a highly conserved domain among eukaryotic organisms there
are plenty of mammalian cyclins to use as templates for the structure of this area.
On the other hand the area hypothesized to bind to TgIMC1 is predicted to be a coiled
region. When this region is included on TgCyc2 the structure predication is poor (-3.61) i.e.
closer to the lowest score possible, which is -5. This indicates that no known related structures
could be found in the protein database and supports the idea that T. gondii’s cell cycle proteins
and Apicomplexa proteins in general are unique eukaryotic proteins. Considering the
distinctiveness of Apicomplexa cell cycle proteins it is not difficult to see why these would be
considered to be potential drug targets. Further, it also supports the idea that TgCyc2 might be
involved in unique functions such as targeting a CDK to a suborganellar location by binding
TgCyc2.
Conclusions
Using yeast two-hybrid testing to search for the area on TgCyc2, which is responsible for
binding TgIMC1, was not meant to provide a conclusive answer, but lead experimentation into
new directions. Determination of the submolecular interaction of proteins provides valuable
information towards function. Additionally, this approach would also never fully explain the
reason for TgCyc2’s ability to bind both TgIMC1 and TgCyc2. Neither would it hone in on the
exact functional domains present in TgCyc2. However, if encouraging results can be achieved
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with the yeast two-hybrid test, which is an economical and timesaving approach, these
encouraging results could warrant further studies. Supplementary testing might include
techniques such as co-immunoprecipitation and indirect immunofluorescence to corroborate
findings from the yeast two-hybrid test.
It will be interesting to follow the future research on the TgCyc2 – TgIMC1 – TgCDK1
interaction. It is worth mentioning here in the concluding remarks that results indicating that the
novel interaction hypothesis between TgCy2 – TgIMC1 – TgCDK1 is corroborated would also
warrant cross-Apicomplexa examination for similar interactions. It will be interesting to see what
the results are from the yeast two-hybrid test suggested here. However, only more experiments
will be able to elucidate if these protein – protein interactions are simply spurious artifacts of the
yeast two-hybrid system or if it could be the basis for developing the next Toxoplasma gondii
drug.
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